Analysts at Stifel have initiated coverage on Allscripts Healthcare Solutions Inc MDRX 0.21%. In a report released Tuesday, analysts issued a Hold rating on Allscripts stock and explained that they see limited growth opportunities for the company.
‘Difficult’ Turnaround
Analysts believe that Allscripts has an uphill battle ahead of it.
According to the report, the company’s potential turnaround story relies on somehow figuring out how to return to 5-8 percent top-line growth and 18-22 percent EBITDA growth over a three-year period. Without greenfield growth opportunities for the company’s electronic health record (EHR) products, analysts struggle to find a convincing growth story for Allscripts.
They note that the majority of the demand for most of the company’s products is government mandate-driven.
Where To Go From Here
Analysts feel that many of the products that Allscripts offers lack true integration, although they note that Sunrise is one exception. Analysts disagree with management’s strategy of maintaining the company’s core EHR systems provider branding. Instead, they suggest that increasing focus on population health and patient portals could be a better path forward.
Analysts note that they see a particular opportunity for Allscripts to differentiate its operations from those of competitors Epic and Cerner Corp CERN 0.97% by “developing and strengthening the value proposition around population health.”
Pressure Coming From Investment Shift
Analysts explain that the value proposition of Allscript’s core EHR product centers on digitization rather than performance. “We believe solid growth and performance in managed IT services will place significant pressure on the core EHR business,” they write.
Allscripts shareholders would certainly love to see some signs of life from the stock, which is down nearly 5 percent in 2015 and more than 30 percent in the past year.
Read this article and all my other articles for free on Benzinga by clicking here
Want to learn more about the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!
